Sacubitril/valsartan for heart failure in adults with complex congenital heart disease

Volume: 300, Pages: 137 - 140
Published: Feb 1, 2020
Abstract
Background Heart failure is an important cause of morbidity and mortality in adults with congenital heart disease (ACHD). Sacubitril/valsartan is an established treatment for heart failure with reduced ejection fraction due to acquired cardiovascular disease. Data in adults with complex congenital heart disease (CHD) is lacking. Methods Retrospective study of ACHD patients with CHD of moderate/severe complexity and heart failure under treatment...
Paper Details
Title
Sacubitril/valsartan for heart failure in adults with complex congenital heart disease
Published Date
Feb 1, 2020
Volume
300
Pages
137 - 140
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.